MoCRA Responsible Person vs U.S. Agent: What's the Difference

The distinction that matters

Under MoCRA, the Responsible Person for a cosmetic product is the manufacturer, packer, or distributor whose name appears on that product’s label and who must submit, or ensure submission of, the product listing to FDA. A U.S. Agent, by contrast, is the domestic contact included in a foreign facility’s registration.

A foreign company can be the Responsible Person without forming a U.S. entity or opening a U.S. office. The U.S. Agent requirement attaches to the registration of a foreign manufacturing or processing facility, not to the Responsible Person’s location by itself. A U.S. Agent must reside in the United States or maintain a U.S. place of business, be physically present in the United States, and cannot be only a mailbox or answering service. FDA registration and listing guidance

The roles can be coordinated by the same service provider, but they are not created in the same way. The Responsible Person’s identity follows the label, while the U.S. Agent is designated in the foreign facility registration. FDA cosmetics registration and listing

Why buyers confuse them

MoCRA created a product-level role that many non-U.S. brands did not have to manage before: the Responsible Person. At the same time, foreign facilities need a U.S.-based contact in FDA registration workflows. That creates an easy but costly mix-up: teams assume a services contract can automatically turn the U.S. Agent into the Responsible Person, or that naming a Responsible Person on the label satisfies the foreign facility contact requirement.

Neither assumption is correct. One role is tied to who is named on the cosmetic label and who owns the product-side obligations; the other is tied to FDA’s ability to reach a foreign facility through a qualified U.S. contact. FDA cosmetics law overview FDA Direct user guide

Responsible Person vs U.S. Agent at a glance

How the filings actually work under MoCRA

A pattern worth naming: facility registration and product listing are connected, but they are not the same filing. Teams often treat them as one step because both happen in FDA’s cosmetics workflow, but they answer different regulatory questions.

• Facility registration is about the manufacturing or processing site. Cosmetic facilities subject to MoCRA must register, update registration information within 60 days of changes, and renew registration every two years. FDA compliance policy update
• Product listing is about each marketed cosmetic product. The Responsible Person must list each marketed product, including ingredients, and provide updates annually. FDA registration and listing page
• Cosmetics Direct is FDA’s electronic portal for both submission types. Sharing one portal does not make the underlying roles interchangeable.

Which role should a foreign cosmetic brand arrange first?

1. Determine the Responsible Person during label planning. Identify which manufacturer, packer, or distributor will appear on the label. This can be the foreign brand itself.
2. Secure the U.S. Agent before submitting the foreign facility registration. The U.S. Agent’s contact information is required in that registration.
3. Complete the facility registration. Product listings generally require the registration number for each facility where the product is manufactured or processed.
4. Submit the product listing. The Responsible Person can submit it directly or authorize another party to file on its behalf.

The two roles should therefore be arranged in parallel, not treated as alternatives. Operationally, the foreign facility registration comes before the associated product listing. FDA registration and listing sequence

What breaks when one role is missing

A foreign cosmetic brand can have a valid Responsible Person and still have a facility-side gap. It can also have a valid U.S. Agent while leaving product-side duties unmanaged.

The brand has a Responsible Person but no valid U.S. Agent

If a foreign manufacturing or processing facility is being registered under MoCRA, the registration must include the facility’s U.S. Agent contact. A missing, outdated, or non-qualifying agent leaves required facility registration information incomplete. If the agent changes, the facility registration must be amended within 60 days. FDA cosmetics registration requirements

The Responsible Person may still be valid because its status comes from the product label. That does not cure the facility record, and a product listing does not substitute for the required U.S. Agent information.

The brand has a U.S. Agent but has not properly identified the Responsible Person

The label-named manufacturer, packer, or distributor is the Responsible Person as a matter of law, even if the team has not used that title internally. The U.S. Agent does not automatically inherit responsibility for product listing, safety substantiation, serious adverse event reporting, or other product-side duties.

The practical failure is an ownership gap: the facility has a domestic FDA contact, but no one is managing the obligations assigned to the label-named party. MoCRA assigns safety substantiation and serious adverse event reporting to the Responsible Person, including a 15-business-day deadline for reporting serious adverse events. FDA MoCRA overview

Three real-world examples

1) UK skincare brand with no U.S. entity or office

The UK brand does not need to create a U.S. company merely to become the Responsible Person. If the brand is the manufacturer, packer, or distributor named on the label, it can remain the Responsible Person and can use qualifying electronic contact information, such as a website, for receiving adverse event reports. Its foreign manufacturing facility separately needs a qualified U.S. Agent in the facility registration.

2) Korean contract manufacturer making products for a U.S. private-label brand

The foreign manufacturing site has the facility-side obligations and needs a U.S. Agent in its registration. If the U.S. private-label company’s name appears on the product label as the manufacturer, packer, or distributor, that company is the Responsible Person. The contract manufacturer, private-label brand, or an authorized agent may handle submissions as permitted, but filing a form does not change which entity the label makes responsible.

3) EU haircare company changing formulas or agent details

If the U.S. Agent changes, the facility registration must be amended within 60 days. If the product listing information changes, the Responsible Person handles the change through the annual product listing update cycle. Operations teams should track facility events and product events separately rather than treating “MoCRA compliance” as one calendar reminder. FDA Direct user guide

Timing rules that tend to get missed

• Facility registration renewal: every two years for facilities required to register. FDA updated Cosmetics Direct in February 2026 to support biennial renewal tracking. FDA February 2026 update
• Facility registration changes: update within 60 days of a change. This includes changes to required U.S. Agent information. FDA cosmetics law overview
• Product listing: each marketed cosmetic product must be listed by the Responsible Person or through an authorized submission made on its behalf.
• Product listing updates: provide updates annually. FDA constituent update

The operational takeaway is simple: the facility has its own renewal and change-management clock, while the product listing has its own annual maintenance clock. A services agreement should assign responsibility for both calendars explicitly.

Common misconceptions

A foreign brand needs a U.S. company to sign as Responsible Person

No. A foreign manufacturer, packer, or distributor can be the Responsible Person if its name appears on the label. An authorized agent may submit the product listing, but the submitter does not become the Responsible Person merely by filing it.

A U.S. Agent services contract automatically transfers Responsible Person status

No. A consultant or U.S. Agent can become the Responsible Person only if it meets the statutory definition and appears on the label as the manufacturer, packer, or distributor. FDA Entry Point’s Responsible Person support model keeps the foreign brand as the legal Responsible Person while providing operational support. FDA Entry Point Responsible Person support

Cosmetics Direct makes the roles interchangeable

No. Cosmetics Direct contains both facility registration and product listing workflows, but the U.S. Agent remains part of the foreign facility record and the Responsible Person remains tied to the product and label. FDA Direct user guide

Related terms

• MoCRA: the Modernization of Cosmetics Regulation Act of 2022, which added facility registration, product listing, adverse event, records access, and other requirements for cosmetics. FDA MoCRA overview
• Cosmetics Direct: FDA’s electronic submission portal for cosmetic facility registration and product listing. FDA Direct guide
• Authorized agent: a party authorized to send facility registration or product listing information on behalf of the owner, operator, or Responsible Person. Submission authority does not by itself transfer the underlying legal role.
• Facility registration: the filing for a cosmetic manufacturing or processing facility subject to MoCRA, renewed every two years and updated within 60 days of changes. FDA cosmetics law overview
• Product listing: the submission the Responsible Person makes or ensures is made for each marketed cosmetic product, including ingredients, with annual updates. FDA registration and listing page
• INCI: International Nomenclature Cosmetic Ingredient names used for cosmetic ingredient labeling; brands use INCI review to check whether ingredient declarations and label presentation align with U.S. cosmetic labeling expectations. FDA Entry Point label review

How one provider can coordinate both workflows

One provider can manage the U.S. Agent workflow, facility registration, product listing submissions, and Responsible Person support under one commercial relationship. That arrangement centralizes execution, but the contract should distinguish between holding a legal role and performing filings or compliance work for the entity that holds it.

FDA Entry Point illustrates this structure in practice. It can serve as the U.S. Agent and support cosmetic facility registration, while its Responsible Person support service helps the label-named brand manage safety records, serious adverse event reporting, recall coordination, and related obligations. The foreign brand remains the legal Responsible Person rather than transferring that status through the services contract.

A combined agreement should identify:

• which manufacturer, packer, or distributor will appear on the product label as the Responsible Person;
• whether the provider is authorized to submit and maintain product listings on that entity’s behalf;
• which firm is designated as U.S. Agent in each foreign facility registration;
• who receives, forwards, and coordinates responses to FDA communications;
• who tracks annual product listing updates, biennial facility renewals, and 60-day facility amendments; and
• how the facility registration will be updated if the U.S. Agent relationship ends.

This is the practical meaning of using one firm for both sides: one team can coordinate the work, while the label and FDA records continue to preserve the two separate legal functions. FDA Entry Point cosmetic U.S. Agent services

Frequently asked questions

Is the Responsible Person the same as the U.S. Agent for cosmetics under MoCRA?

No. The Responsible Person is the manufacturer, packer, or distributor named on the product label, while the U.S. Agent is the domestic contact included in a foreign facility’s registration. The Responsible Person owns product-side obligations, including product listing, and the U.S. Agent fills the facility-side contact role. FDA cosmetics registration and listing

Who signs as Responsible Person if my cosmetics brand has no U.S. office?

Your foreign company can remain the Responsible Person if it is the manufacturer, packer, or distributor whose name appears on the product label. A U.S. office or U.S. subsidiary is not required for Responsible Person status. An authorized agent can submit the product listing on the foreign company’s behalf, but the foreign label-named company remains the Responsible Person. FDA registration and listing guidance

Can my U.S. Agent also act as my MoCRA Responsible Person?

Only if the U.S. Agent independently qualifies as the manufacturer, packer, or distributor and its name appears on the product label. Merely signing a U.S. Agent or compliance services agreement does not transfer Responsible Person status. A provider can serve as U.S. Agent and support the label-named brand’s product listings, safety records, and adverse event work without becoming the legal Responsible Person. FDA MoCRA role definition

What happens if my cosmetic brand has a Responsible Person but no U.S. Agent?

If the brand’s foreign manufacturing or processing facility must be registered, its facility registration is missing required U.S. Agent information. The Responsible Person can still be valid because that role follows the product label, but the product-side role does not satisfy the foreign facility contact requirement. The reverse is also true: a valid U.S. Agent does not take over product listing, safety substantiation, or serious adverse event duties from the Responsible Person. FDA cosmetics law overview

Should I appoint a Responsible Person or a U.S. Agent first for a foreign cosmetic brand?

Identify the Responsible Person during label planning, then secure the U.S. Agent before submitting the foreign facility registration. The facility registration should generally be completed before the product listing because the listing ordinarily includes each manufacturing or processing facility’s registration number. The two roles should be arranged together, but they enter different FDA records. FDA filing sequence guidance

References

• FDA: Registration and Listing of Cosmetic Product Facilities and Products
• FDA: Guidance for Industry, Registration and Listing of Cosmetic Product Facilities and Products
• FDA: Modernization of Cosmetics Regulation Act of 2022
• FDA: Cosmetics and U.S. Law
• FDA: FDA Direct User’s Guide, Cosmetics Direct, February 2026
• FDA: Compliance Policy for Cosmetic Product Facility Registration and Product Listing
• FDA: Registration and Listing Deadline and Filing Sequence
• FDA: Summary of Cosmetics Labeling Requirements
• FDA Entry Point: Responsible Person Support
• FDA Entry Point: U.S. Agent Services for Cosmetics
• FDA Entry Point: Cosmetic Facility Registration
• FDA Entry Point: Cosmetic Label Review and INCI